Through the 90-day period concluding February 10, 2026, Arcturus Therapeutics Holdings's top three insider stakeholders include President And Ceo Joseph E Payne (1.48Mn shares), Director Pharmaceutical Inc. Ultragenyx (1.40Mn shares), Chief Scientific Officer & Coo Pad Chivukula (435.33K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Joseph E Payne | President And Ceo | 1,480,097 | 28 Nov, 2022 |
| Pharmaceutical Inc. Ultragenyx | 1,400,000 | 12 Aug, 2021 | |
| Pad Chivukula | Chief Scientific Officer & Coo | 435,334 | 16 Oct, 2024 |
| Andy Sassine | Chief Financial Officer | 221,764 | 20 Aug, 2025 |
| Peter C Farrell | 55,741 | 18 Jun, 2024 | |
| Magda Marquet | 28,073 | 18 Jun, 2024 | |
| James F Barlow | 13,131 | 18 Jun, 2024 | |
| Edward W Holmes | 3,131 | 18 Jun, 2024 | |
| John Markels | 3,131 | 18 Jun, 2024 | |
| Jing L. Marantz | 3,131 | 18 Jun, 2024 | |
| Keith C Kummerfeld | Nan | 950 | 18 Jul, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Aug, 2025 | Andy Sassine | Common Stock | D | 1,238 | $16.56 | 221,764 | D | P |
| 15 Aug, 2025 | Andy Sassine | Common Stock | A | 1,238 | $16.56 | 221,764 | D | P |
| 15 Oct, 2024 | Pad Chivukula | Common Stock | D | 12,000 | $20.76 | 435,334 | D | S |
| 15 Oct, 2024 | Pad Chivukula | - | - | 435,334 | D | |||
| 14 Jun, 2024 | Peter C Farrell | Common Stock | A | 3,131 | $0.00 | 55,741 | D | M |
| 14 Jun, 2024 | James F Barlow | Common Stock | A | 3,131 | $0.00 | 13,131 | D | M |
| 14 Jun, 2024 | Edward W Holmes | Common Stock | A | 3,131 | $0.00 | 3,131 | D | M |
| 14 Jun, 2024 | Magda Marquet | - | - | 3,131 | D | |||
| 14 Jun, 2024 | Magda Marquet | Common Stock | A | 3,131 | $0.00 | 3,131 | D | M |
| 14 Jun, 2024 | John Markels | Common Stock | A | 3,131 | $0.00 | 3,131 | D | M |
| 14 Jun, 2024 | Jing L. Marantz | Common Stock | A | 3,131 | $0.00 | 3,131 | D | M |
| 12 Jun, 2024 | Andy Sassine | - | - | 220,526 | D | |||
| 12 Jun, 2024 | Andy Sassine | Common Stock | D | 50,000 | $32.03 | 220,526 | D | S |
| 05 Jun, 2024 | Pad Chivukula | Common Stock | D | 114 | $45.00 | 447,334 | D | S |
| 03 Jun, 2024 | Pad Chivukula | Common Stock | D | 26,000 | $40.01 | 447,448 | D | S |
| 25 Mar, 2024 | Pad Chivukula | Common Stock | D | 17,435 | $35.02 | 473,448 | D | S |
| 19 Mar, 2024 | Pad Chivukula | Common Stock | D | 8,565 | $35.01 | 490,883 | D | S |
| 01 Nov, 2023 | Pad Chivukula | Common Stock | D | 5,000 | $18.72 | 499,448 | D | S |
| 02 Oct, 2023 | Pad Chivukula | Common Stock | D | 5,000 | $25.61 | 504,448 | D | S |
| 01 Sep, 2023 | Pad Chivukula | Common Stock | D | 5,000 | $31.45 | 509,448 | D | S |